structur
determin
envelop
glycoprotein
env
present
number
challeng
sever
highresolut
structur
becom
avail
cryoem
xray
structur
solubl
cleav
sosip
env
trimer
clade
strain
provid
first
glimps
env
trimer
fold
well
variabl
region
recent
cryoem
structur
nativ
fulllength
trimer
without
stabil
mutat
core
structur
reveal
new
insight
featur
comprehens
higher
resolut
understand
glycan
shield
also
emerg
enabl
complet
represent
env
glycoprotein
structur
complex
env
trimer
broadli
neutral
antibodi
surprisingli
illustr
env
surfac
target
natur
infect
neutral
epitop
almost
compos
peptid
glycan
compon
structur
also
provid
evid
inher
plastic
env
antibodi
exploit
flexibl
perturb
even
stabil
trimer
facilit
neutral
breakthrough
stimul
design
stabil
env
trimer
well
platform
gener
trimer
span
multipl
subtyp
env
trimer
use
immunogen
led
first
vaccineinduc
neutral
antibodi
structur
function
analys
cryoelectron
microscopi
epitop
map
glycan
shield
hiv
envelop
structur
structurebas
vaccin
design
xray
crystallographi
recombin
express
system
well
stabil
solubl
version
glycoprotein
essenti
success
structur
determin
even
influenza
hemagglutinin
robust
recombin
express
system
could
provid
suffici
quantiti
structur
studi
develop
despit
best
effort
commun
worldwid
develop
stabil
env
trimer
john
moor
jame
binley
rogier
sander
promis
solut
found
env
engin
disulfid
so
coval
hold
subunit
togeth
isoleucin
prolin
mutat
region
aid
trimer
format
led
stabil
trimer
call
sosip
final
enabl
solubl
cleav
env
trimer
assembl
express
review
issu
sander
moor
took
anoth
year
find
candid
env
optim
solubl
stabil
well
suffici
express
level
highresolut
structur
undertaken
cryoelectron
microscopi
cryoem
xray
crystallographi
viral
glycoprotein
prove
equal
challeng
product
recombin
engin
protein
also
essenti
determin
threedimension
structur
exampl
includ
f
glycoprotein
parainfluenza
viru
glycoprotein
g
vesicular
stomat
viru
fusion
protein
respiratori
syncyti
viru
ebola
viru
glycoprotein
core
protein
hepat
c
viru
human
coronaviru
spike
glycoprotein
prefus
glycoprotein
lcmv
fulllength
herp
simplex
viru
glycoprotein
b
phlebovir
envelop
glycoprotein
puumala
viru
gn
glycoprotein
hemagglutininesteras
rat
coronaviru
mous
hepat
viru
mani
recent
structur
illustr
signific
advanc
made
structur
determin
viral
glycoprotein
first
structur
env
compon
came
via
crystal
structur
postfus
conform
helic
domain
peter
kim
wiley
min
lu
follow
year
peter
kwong
rich
wyatt
joe
sodroski
wayn
hendrickson
mani
year
innov
work
determin
crystal
structur
core
domain
complex
solubl
neutral
antibodi
mani
year
core
becam
gold
standard
analyz
interact
antibodi
ligand
gradual
complet
increas
ad
variabl
loop
region
nand
ctermini
interact
eventu
unligand
structur
obtain
look
remark
similar
receptorbound
form
interim
descript
analysi
env
trimer
remain
domain
electron
microscopi
particularli
cryoelectron
tomographi
cryoet
low
resolut
snapshot
env
trimer
surfac
siv
hiv
gener
controversi
exact
natur
trimer
configur
whether
base
resembl
tripod
trimer
helic
bundl
question
still
remain
unansw
becam
clear
bind
induc
chang
trimer
much
open
trimer
apex
fab
antibodi
bound
bind
site
flexibl
natur
trimer
thu
becam
appar
earli
cryoet
work
studi
cryoem
reveal
multipl
conform
env
trimer
relat
conform
rearrang
trimer
must
undergo
attain
fusionact
form
receptor
bind
well
structur
prefus
form
importantli
antibodi
shown
stabil
prefus
close
form
trimer
solubl
form
trimer
structur
determin
proceed
slowli
despit
advent
sosip
trimer
lab
tri
crystal
origin
clade
b
jrfl
sosip
trimer
collabor
john
moor
rogier
sander
start
much
later
found
work
see
chang
env
sequenc
clade
strain
complex
fab
led
rob
pejchal
wilson
lab
obtain
beauti
crystal
excel
morpholog
inde
diffract
xray
resolut
becam
clear
aggreg
trimer
problem
construct
consider
experiment
truncat
hydrophob
mper
residu
instead
residu
origin
construct
substanti
improv
biophys
properti
elimin
micel
around
base
clearli
visual
negativestain
em
result
crystal
materi
diffract
complex
differ
fab
interact
high
mannos
patch
center
around
glycan
improv
env
properti
sosip
construct
made
mani
differ
strain
electron
microscopi
led
critic
advanc
construct
screen
clade
sosip
trimer
look
best
negativestain
em
term
trimer
compact
properli
fold
emul
trimer
surfac
viru
thu
trimer
select
immunolog
structur
studi
found
stabl
melt
temperatur
tm
bound
known
broadli
neutral
antibodi
except
mper
ab
mper
present
construct
highli
homogen
fold
nativelik
structur
evalu
quantit
negativestain
em
import
cleavag
attain
nativ
conform
also
demonstr
critic
solubl
cleav
sosip
trimer
becam
templat
achiev
longawait
env
trimer
structur
broadli
neutral
antibodi
also
play
crucial
role
structur
determin
xray
crystallographi
cryoelectron
microscopi
hand
bnab
avail
facilit
crystal
highli
glycosyl
trimer
signific
advanc
method
isol
human
monoclon
antibodi
hiv
review
either
direct
neutral
screen
singl
b
cell
cultur
antigenspecif
b
cell
sort
provid
rich
plenti
assort
structur
function
studi
inde
recombin
sosip
trimer
later
use
select
potent
antibodi
date
env
trimer
result
mani
antibodi
becam
avail
aid
crystal
env
trimer
howev
heterogen
glycosyl
env
still
problem
partial
deglycosyl
antibodysosip
trimer
complex
use
endoh
abl
creat
homogen
specimen
use
previous
fab
complex
diffractionqu
crystal
obtain
jeanphilipp
julien
wilson
lab
make
myriad
complex
sosip
env
differ
fab
deglycosyl
set
crystal
trial
screen
crystal
find
crystal
diffract
suffici
well
determin
env
structur
thu
year
first
attempt
crystal
jrfl
sosip
trimer
suitabl
crystal
obtain
sosip
trimer
end
storyfar
ward
lab
use
em
select
character
suitabl
env
trimer
structur
studi
howev
em
studi
initi
intend
aid
env
structur
work
xray
major
advanc
cryoem
suggest
possibl
determin
structur
singl
particl
subnanomet
resolut
facilit
detect
align
env
particl
antibodi
complex
solubl
sosip
trimer
consider
effort
overcom
sampl
aggreg
prefer
orient
cryoem
structur
determin
dmitri
lyumki
ward
lab
approxim
resolut
furthermor
low
resolut
em
envelop
bound
crucial
molecular
replac
solut
xray
structur
thu
em
caught
sens
surpass
xray
achiev
structur
challeng
glycoprotein
first
view
high
resolut
came
cryoem
also
crystal
requir
nativ
glycan
could
left
env
protein
enabl
visual
nativelik
complet
glycan
shield
addit
protein
compon
result
structur
sosip
cryoem
complex
xray
complex
high
mannos
glycan
patch
resolut
respect
provid
first
atomiclevel
view
solubl
env
trimer
structur
disclos
intim
associ
compon
prefus
helic
structur
central
tripl
coiledcoil
helic
close
interact
hypervari
loop
around
env
trimer
apex
figur
furthermor
broadli
neutral
epitop
bind
site
high
mannos
patch
visual
context
trimer
illustr
difficult
rais
bnab
individu
compon
trimer
antibodi
approach
way
permit
trimer
context
ie
nonneutr
antibodi
usual
gener
use
malform
trimer
immunogen
em
xray
structur
highli
complement
laid
foundat
understand
intrins
beauti
sheer
complex
env
trimer
structur
design
version
solubl
trimer
differ
strain
subtyp
next
major
step
improv
resolut
env
trimer
structur
peter
kwong
colleagu
util
sosip
construct
experi
mix
match
antibodi
origin
fab
provid
good
lattic
contact
env
trimer
resolut
anisotropi
diffract
ideal
addit
newli
discov
antibodi
f
g
u
r
e
env
trimer
architectur
crystal
structur
sosip
env
pdb
differ
region
trimer
describ
main
text
color
accordingli
gray
trimer
apex
magenta
loop
cyan
loop
red
brown
ntermin
region
n
green
fusion
peptid
yellow
dash
line
indic
locat
flexibl
typic
disord
region
trimer
structur
n
region
green
also
usual
disord
sosip
structur
although
fulli
resolv
region
nativ
env
trimer
lack
sosip
mutat
adopt
helic
topolog
pdb
b
overlay
env
trimer
structur
date
determin
cryoem
xray
crystallographi
resolut
pdb
demonstr
conserv
fold
trimer
small
differ
variabl
loop
peripheri
trimer
arrow
indic
fusion
peptid
two
differ
structur
magenta
green
demonstr
highli
flexibl
natur
mark
connor
laboratori
led
crystal
increas
resolut
approxim
although
still
consider
anisotropi
complet
structur
env
trimer
reveal
fascin
new
detail
prefus
conform
includ
so
disulfid
intric
arrang
nand
ctermin
region
base
trimer
tryptophan
clasp
lock
fusion
peptid
proxim
region
prefus
conform
figur
lab
also
continu
explor
differ
combin
antibodi
search
elus
env
trimer
crystal
diffract
basebind
antibodi
also
aid
crystal
antibodi
induc
local
structur
chang
within
proxim
epitop
particularli
variabl
loop
fusion
peptid
glycan
data
shown
subtl
differ
obviou
imag
figur
domain
figur
perhap
unexpectedli
much
extens
highli
order
glycan
shield
visual
consist
high
mannos
glycan
clade
g
env
similar
outcom
clade
b
trimer
three
type
glycanglycan
interact
observ
depend
distanc
glycan
compar
densiti
surround
glycan
closer
distanc
neighbor
glycan
splay
apart
wherea
intermedi
distanc
allow
upright
interact
tip
much
like
canopi
dens
forest
longer
interglycan
distanc
permit
order
glycanglycan
interact
henc
fewer
sugar
moieti
observ
site
extens
order
network
interact
appear
fli
face
carbohydr
model
env
surfac
previous
observ
rapidli
flicker
hot
coal
prior
structur
mention
cryoem
also
use
visual
glycan
shieldthi
time
nativ
glycan
includ
complex
hybrid
high
mannos
glycoform
atom
resolut
one
almost
fulllength
nativ
structur
determin
jeong
hyun
lee
ward
lab
use
cryoem
stabil
mutat
figur
membran
proxim
extern
region
mper
membranespan
region
intact
cytoplasm
tail
delet
construct
extens
complex
triand
tetraantennari
sugar
seen
particularli
interact
bnab
use
extract
stabil
trimer
membran
extens
glycan
canopi
seen
xray
structur
resolv
differ
glycan
observ
xray
em
structur
crystal
structur
glycan
homogen
high
mannos
em
structur
glycan
much
divers
heterogen
would
lead
fewer
glycan
visual
multipl
glycoform
present
mani
posit
especi
mainli
consist
complex
hybrid
glycan
high
mannos
patch
rel
homogen
fewer
sugar
glycan
interact
seen
em
structur
natur
glycan
process
may
extent
account
depend
entir
constel
glycan
surround
everi
glycaneven
high
mannos
patch
complex
hybrid
sugar
interspers
surround
high
mannos
cluster
may
make
heterogen
nativ
versu
high
mannos
glycoprotein
complet
homogen
high
mannos
sugar
may
also
greater
tendenc
cluster
form
defin
interact
still
verifi
xray
structur
also
complex
antibodi
interact
help
order
glycan
note
previou
xray
em
studi
xray
structur
two
antibodi
bound
one
wherea
cryoem
structur
one
antibodi
bound
asymmetr
two
per
trimer
interfac
thu
nine
antibodi
bound
per
trimer
xray
structur
two
per
trimer
em
structur
notabl
order
glycan
xray
structur
well
complex
glycan
cryoem
structur
proxim
antibodi
bound
xray
structur
sosip
three
fab
bound
per
trimer
also
show
highli
order
high
mannos
glycan
surround
bound
antibodi
thu
wellappreci
antibodi
bind
glycopeptid
epitop
help
order
glycan
part
proxim
epitop
final
might
possibl
crystal
select
order
glycoform
crystal
buffer
low
ph
may
artifici
promot
glycanglycan
interact
notwithstand
great
swath
suppl
sugar
number
around
cover
hiv
env
surfac
form
protect
glycocalyx
outstand
question
remain
exact
composit
glycan
glycoform
individu
glycosyl
site
within
env
trimer
figur
order
construct
complet
model
env
trimer
includ
glycan
shield
essenti
know
specif
glycan
collect
glycan
built
xray
electron
densiti
em
reconstruct
known
time
high
level
glycan
homogen
exist
region
known
high
mannos
patch
figur
due
steric
crowd
imped
secondari
process
high
mannos
sugar
complex
glycoform
glycosidas
secondari
process
take
place
golgi
protein
fulli
fold
henc
reflect
either
capabl
inabl
glycosidas
access
glycan
substrat
env
protein
see
figur
thu
tightli
crowd
high
mannos
patch
outer
surfac
essenti
independ
cell
line
use
protein
express
glycan
site
apart
figur
complex
hybrid
glycan
predomin
glycosyl
becom
celllin
depend
due
differenti
activ
glycosidas
differ
cell
line
anoth
import
featur
cleavag
trimer
critic
attain
proper
nativelik
glycosylationuncleav
trimer
process
glycoform
indic
structur
fold
close
nativ
conform
inde
nonn
uncleav
protein
also
contain
aberr
disulfid
bond
thu
substanti
breakthrough
requir
quantit
glycan
composit
individu
glycosyl
site
achiev
recent
use
mass
spectrometri
analyz
glycoform
env
trimer
sitespecif
glycosyl
separ
site
essenti
high
mannos
complex
site
mixtur
glycoform
type
present
high
mannos
patch
extend
like
belt
around
central
region
trimer
complex
form
mainli
locat
trimer
apex
base
mix
form
scatter
spars
throughout
figur
thu
new
glycan
inform
invalu
construct
best
model
env
glycoprotein
also
design
immunogen
accur
mimic
viral
env
inde
use
effect
immunogen
elicit
autolog
tier
neutral
antibodi
respons
anim
model
kwong
group
similarli
use
platform
construct
trimer
clade
b
g
thu
sosip
trimer
platform
success
appli
mani
differ
strain
subtyp
figur
thu
gener
util
produc
solubl
env
trimer
structur
vaccin
studi
platform
also
explor
product
env
trimer
figur
discuss
express
uncleav
trimer
contain
foldon
leuzipp
domain
trimer
fold
nativelik
configur
focu
recent
platform
nativelik
env
conform
obtain
use
differ
design
two
design
modifi
cleavag
site
figur
one
design
term
nativ
flexibl
link
nfl
replac
natur
cleavag
sequenc
rekr
gli
ser
linker
natur
cterminu
nterminu
two
repeat
optim
flexibl
linker
also
increas
distanc
normal
cterminu
nterminu
appear
allow
uncleav
trimer
jrfl
backbon
achiev
nativelik
configur
absenc
cleavag
furin
howev
mutat
necessari
stabil
sosip
trimer
also
requir
nfl
platform
use
express
env
protein
b
c
subtyp
incorpor
residu
import
trimer
format
call
trimerderiv
residu
td
similar
design
also
experi
insert
glyser
linker
place
cleavag
sequenc
backbon
linker
residu
gave
optim
properti
construct
maintain
sosip
mutat
so
ip
thu
design
result
solubl
env
trimer
need
furin
cleavag
achiev
nativelik
conform
henc
could
potenti
simplifi
express
env
trimer
use
avail
env
trimer
structur
effort
stabil
solubl
env
trimer
immunogen
design
undertaken
effort
quit
success
increas
melt
temperatur
trimer
approxim
varieti
mutat
introduc
stabil
close
prefus
conform
env
trimer
also
engin
disulfid
bridg
sheet
prevent
conform
chang
bound
form
anoth
recent
design
focus
redesign
larg
disord
loop
n
solubl
env
construct
connect
central
helix
fppr
stabl
trimer
express
well
obtain
use
design
shorter
n
region
use
product
nativelik
structur
replac
cleavag
site
design
short
long
linker
led
anoth
platform
use
produc
solubl
env
trimer
call
ufo
trimer
figur
high
puriti
yield
differ
hiv
strain
subtyp
focus
far
way
make
solubl
stabl
env
trimer
structur
immunolog
vaccin
studi
howev
viral
fusion
glycoprotein
gener
metast
undergo
complex
conform
rearrang
transit
prefus
form
bind
receptor
postfus
form
abl
fuse
viral
membran
host
cell
membran
transfer
viral
genom
cell
replic
howev
appear
env
protein
unstabl
counterpart
influenza
viru
envelop
glycoprotein
hemagglutinin
readili
cleav
viru
express
solubl
highli
stabl
protein
rsv
protein
also
quit
unstabl
readili
adopt
postfus
form
even
surfac
viru
cell
entri
recent
studi
walther
moth
colleagu
use
singlemolecul
fluoresc
reson
energi
transfer
fret
vividli
demonstr
unligand
hiv
env
intrins
dynam
flicker
three
distinct
conform
viral
surfac
bind
bnab
well
natur
receptor
influenc
rel
distribut
conform
thu
surpris
recombin
form
env
protein
also
similar
dampen
dynam
charact
inher
protein
engin
express
system
use
flexibl
manifest
reactiv
condit
eg
elisa
solubl
sosip
trimer
antibodi
appear
slight
open
apex
expos
highli
immunogen
loop
inde
differ
strain
subtyp
appear
vari
extent
fulli
close
viral
protein
influenza
hemagglutinin
fusion
peptid
fp
buri
deepli
subunit
within
trimer
core
fusion
peptid
highli
conserv
sequenc
nterminu
liber
furin
cleavag
fusion
peptid
observ
initi
solubl
env
protein
structur
locat
fusion
peptid
proxim
region
suggest
might
inde
close
viral
surfac
sosip
structur
first
residu
fp
point
toward
solvent
disord
unlik
type
fusion
viral
glycoprotein
fp
appear
point
away
core
trimer
extend
past
toward
glycan
full
fusion
peptid
recent
resolv
presenc
bnab
target
region
figur
fusion
peptid
fulli
expos
structur
interfac
antibodi
env
surfac
constitut
major
compon
epitop
thu
somewhat
unexpectedli
fusion
peptid
access
antibodi
becom
yet
anoth
target
hiv
vaccin
design
highli
glycosyl
surfac
env
present
barrier
bnab
must
negoti
access
peptid
surfac
either
directli
bind
glycan
avoid
much
possibl
thu
epitop
except
compris
mixtur
peptid
glycan
element
review
avail
peptid
surfac
env
outsid
typic
small
bnab
long
cdr
loop
navig
glycan
shield
contact
underli
protein
residu
access
epitop
compos
glycan
peptid
residu
recent
immun
rabbit
sosip
trimer
result
neutral
antibodi
respons
direct
breach
glycan
shield
glycan
present
strain
subtyp
three
glycan
absent
compar
glycosyl
env
protein
antibodi
seem
abl
access
glycan
hole
readili
within
individu
infect
month
year
bnab
evolv
perhap
allow
immun
system
time
target
mani
site
addit
receptor
bind
site
fusion
domain
mani
broadli
neutral
antibodi
also
target
high
mannos
patch
homogen
glycan
conserv
one
might
imagin
given
normal
glycan
heterogen
antibodi
also
appear
effect
stabil
prefus
version
env
trimer
therebi
prevent
conform
chang
rearrang
associ
receptor
coreceptor
bind
fusion
remark
short
space
year
xray
cryoem
structur
env
trimer
resolut
determin
given
atomiclevel
structur
exist
combin
differ
factor
contribut
recent
success
includ
critic
develop
stabl
solubl
trimer
nativelik
amen
highresolut
structur
studi
equal
import
compon
structur
determin
divers
assort
human
broadli
neutral
antibodi
becam
increasingli
avail
fab
antibodi
could
exploit
combinatori
manner
use
highthroughput
crystal
screen
env
trimer
robot
system
eg
see
improv
odd
form
crystal
lattic
minim
contact
heterogen
glycosyl
env
trimer
could
produc
crystal
diffract
high
resolut
antibodi
also
import
crystal
also
provid
appropri
mass
featur
singl
particl
cryoem
furthermor
antibodi
complex
elucid
structur
featur
broadli
neutral
epitop
context
trimer
acceler
design
immunogen
vaccin
candid
solubl
env
trimer
strain
provid
major
structur
determin
date
sosip
platform
turn
transfer
strain
subtyp
figur
breakthrough
inspir
design
platform
capit
stabil
mutat
prove
critic
sosip
construct
figur
becam
clear
uncleav
trimer
fold
compact
trimer
two
group
explor
replac
cleavag
site
linker
would
provid
flexibl
enabl
uncleav
trimer
adopt
nativelik
prefus
trimer
configur
figur
origin
mutat
essenti
stabil
sosip
trimer
highli
flexibl
loop
zip
helic
structur
postfus
form
receptor
coreceptor
bind
prolin
mutat
reduc
propens
conform
chang
anoth
design
effort
loop
assum
major
caus
trimer
metastabilitythu
n
loop
shorten
modifi
sequenc
prevent
helic
postfus
conform
combin
addit
flexibl
linker
led
platform
produc
good
yield
solubl
trimer
divers
array
strain
subtyp
figur
thu
within
short
span
year
new
env
trimer
produc
differ
backbon
differ
platform
increas
stabil
clearli
illustr
modif
perturb
conserv
env
trimer
fold
could
accommod
region
sequenc
structur
hypervari
figur
next
major
breakthrough
came
determin
structur
nativ
trimer
without
stabil
mutat
antibodi
stabil
nativ
trimer
membran
enabl
nativ
trimer
extract
structur
studi
cryoem
structur
almost
fulllength
jrfl
nativ
trimer
mper
transmembran
domain
without
cytoplasm
domain
determin
compar
solubl
env
protein
figur
subtl
differ
seen
apex
fppr
overal
fold
similar
nativ
solubl
trimer
put
rest
linger
question
differ
solubl
versu
nativ
trimer
glycan
shield
look
like
also
address
studi
figur
well
sitespecif
inform
composit
glycoform
individu
glycosyl
site
thu
excel
graphic
represent
glycan
cover
protect
env
protein
surfac
structur
function
analys
figur
myriad
complex
divers
antibodi
also
uncov
much
greater
number
broadli
neutral
epitop
expect
provid
invalu
inform
design
immunogen
vaccin
candid
next
structur
biologist
alway
tri
achiev
highest
resolut
structur
provid
better
understand
structur
function
push
resolut
around
also
aid
substanti
immunogen
design
achiev
better
crystal
particular
util
enorm
advanc
cryoem
undoubtedli
enabl
current
barrier
broken
differ
function
form
trimer
receptor
coreceptor
high
resolut
also
provid
invalu
inform
metast
trimer
transit
prefus
intermedi
fusionact
form
design
germlin
trimer
kick
start
immun
respons
along
path
known
produc
bnab
hivinfect
individu
may
also
instrument
arriv
better
vaccin
candid
thu
taken
time
structur
inform
hiv
env
trimer
come
impress
pace
markedli
acceler
search
elus
hiv
vaccin
